Cannabidiol (CBD) is one of the phytocannabinoids found in the cannabis plant. According to multiple scientific and medical sources, CBD has important medical benefits. Since 2013, the National Institutes of Health (PubMed) service has included over 1,100 studies on CBD in its index.
The U.S. Food and Drug Administration today approved the first generic versions of Abilify (aripiprazole). Generic aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and bipolar disorder. Alembic Pharmaceuticals Ltd., Hetero Labs Ltd., Teva Pharmaceuticals and Torrent Pharmaceuticals Ltd. have received FDA approval to market generic aripiprazole in multiple strengths and dosage forms.
Elderly pati ents with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. ABILIFY is not approved for the treatment of patients with dementia-related psychosis [see WARNINGS AND PRECAUTIONS].